Jeffery W. Kelly

賞

1. 2022

   ブレークスルー賞 — ライフサイエンス

   生物学

   for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.

2. 2023

   ウルフ賞 — 化学

   化学

   for developing a clinical strategy to ameliorate pathological protein aggregation.

3. 2026

   カナダ・ガードナー国際賞

   生物学

   For discovering the anti-aggregation drug, tafamidis, the first effective treatment for a human amyloid disease, specifically transthyretin amyloidosis, providing the first pharmacological evidence that protein aggregation drives neurodegeneration.